Article

Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis…

International Journal of Endocrinology · 2018 · L. Guiducci, author C. Vassalle, author P. Parchi, author S. Maffei, author Patrizia D'Amelio, Academic Editor

Key facts

Title Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study
First author L. Guiducci, author C. Vassalle, author P. Parchi, author S. Maffei, author Patrizia D'Amelio, Academic Editor
Journal International Journal of Endocrinology
Published Jun 6, 2018
DOI 10.1155/2019/9802827
Devices mentioned K002711, K023398, K033224, K073390, K113793, K141463, K150879, K883280, K894795, K905691, K905753, K913321 and 2 more
Product codes mentioned CEW, KGI, LFX, LPS, MRG, CJE, JIX, JJX, MYL, NCD

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature